RAC1 and cancer: Along this line, the fact that we found the C-terminal polyproline-rich region of 28 amino acids to be responsible for binding to PAK1 may provide a starting point for evaluating peptide-based inhibitors that block the Rac1 signaling pathway in endometrial and possibly other types of cancers.